RESEARCH
REPORTS
WALL STREET RESEARCHER
We
have recently published the following Research Reports:
Research Report - LiveCare Inc -LVCE OTC
This tele-health
company,specializing in type II diabetes, is expanding
rapidly , acquiring new members at a record rate.The company
projects $96 Million in revenues and $52 million in profits
by fiscal 2025. We feel these shares have
significant upside potential .
Research Report -
Winc, Inc - NYSE WBEV
This company produces organic wines distributing to major
national retailers including Walmart,
Whole Foods, Albertsons, HEB, Central Market, and HyVee,
In addition the company distributes on- line to retail
buyers of fine wines. A recent $22 Million IPO has provided
expansion and advertising funding .
Research Report - Pressure BioSciences -
PBIO OTC
A life sciences company
producing medical lab equipment .The company produces
three pressure based platforms, all of which are patented.
One of those is the Ultra Shear Technology, the other is
Pressure Cycling Technology and the third is the Bare
Fold Platform..
Research Report - Halberd Corp - HALB OTC
Biotech company working
closely with Youngstown State University and Arizona State
University develop safe and successful treatments for such
diseases as . Alzheimers, PTSD, and Chronic Traumatic
Encephalopathy. Halberd proposes treatments that include the
cleansing bodily fluids through extracorporeal lasar
methodolgy..
Research Report - Houston Natural Resources -
HNRC OTC
This oil sevice waste water
disposal - cleaning and remediation company has
recently advanced on strong Q4 earnings with nine month revs
up 81% . Total assets have doubled over the past three years
to over $73 million .
Research Report - Graystone Company - GYST OTC
This company is a
Bitcoin miner . Using an array of state of the art
high speed computers , this company operates at the leading
edge of technology . In addition to mining
Bitcoin, this company sells its S19j Pro high speed
computer array along with offering hosting services to other
miners.
Neither PSN or WSR nor its owners, members, officers,
directors, partners, consultants, nor anyone involved in the
publication of this website, is a registered investment
adviser or broker-dealer or associated person with a
registered investment adviser or broker-dealer and none of
the foregoing make any recommendation that the purchase or
sale of securities of any company profiled in the PSN or WSR
website is suitable or advisable for any person or that an
investment or transaction in such securities will be
profitable. The information contained in the PSN or WSR
website is not intended to be, and shall not constitute, an
offer to sell nor the solicitation of any offer to buy any
security. The information presented in the PSN or WSR
website is provided for informational purposes only and is
not to be treated as advice or a recommendation to make any
specific investment. Please consult with an independent
investment adviser and qualified investment professional
before making an investment decision. Writer charges a fee
of $7500 per Resaearch Report. All Research Reports are
reviewed by company mamagement for accuracy and concur that
any conclusions made are reasonable expectations. The
term Buy List referring to a Watch List and not a
recommendation to buy . Each individual has their own risk
level and should know their risk level and act accordingly
|